KRO
Kronos Worldwide, Inc.
NYSEUSDEQUITY
Basic Materials
DELAYED
Buy
+23/100
Last price
7.86
▼ 0.08 (1.01%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
7.94
Day high
8.06
Day low
7.85
Volume
167.94K
Market cap
$904.67M
P/E (TTM)
—
52W range
4.08 – 9.17
Trailing performance
Returnvs SPY
1W
-0.76%
-2.7%
1M
-6.76%
-7.9%
3M
+33.67%
+29.2%
6M
+22.24%
+4.1%
YTD
+77.83%
+63.6%
1Y
+37.41%
+21.0%
3Y
+1.42%
-80.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on KRO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
93.54M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 18, 26 | KRAMER KEVIN B Director |
BUY | 14.60K | $98.51K | Direct |
| May 13, 26 | TURNER R GERALD Director |
STOCK | 5.55K | $40.07K | Direct |
| May 13, 26 | MOORE CECIL H JR Director |
STOCK | 5.55K | $40.07K | Direct |
| May 13, 26 | HARPER JOHN E Director |
STOCK | 5.55K | $40.07K | Direct |
| May 13, 26 | CHRISTIAN BRIAN W Chief Executive Officer |
STOCK | 5.55K | $40.07K | Direct |
| May 13, 26 | KRAMER KEVIN B Director |
STOCK | 5.55K | $40.07K | Direct |
| May 13, 26 | FEEHAN LORETTA J. Director |
STOCK | 5.55K | $40.07K | Direct |
| May 13, 26 | MENDES MEREDITH WISE Director |
STOCK | 5.55K | $40.07K | Direct |
| May 13, 26 | SIMMONS MICHAEL SHAWN Chairman of the Board |
STOCK | 5.55K | $40.07K | Direct |
| Aug 15, 25 | MCCOY KRISTIN B. Officer |
BUY | 2.00K | $12.10K | Direct |
| Aug 13, 25 | NACE ANDREW B Officer |
BUY | 3.00K | $17.50K | Direct |
| Aug 11, 25 | SAMFORD AMY A Officer |
BUY | 3.00K | $14.47K | Direct |
| Aug 11, 25 | HANLEY BRYAN A Officer and Treasurer |
BUY | 2.50K | $12.25K | Direct |
| Aug 11, 25 | SIMMONS MICHAEL SHAWN Officer and Director |
BUY | 5.00K | $24.35K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
FEEHAN LORETTA J. |
Director | 26.80K | Stock Award(Grant) |
HANLEY BRYAN A |
Officer and Treasurer | 6.00K | Purchase |
HARPER JOHN E |
Director | 21.80K | Stock Award(Grant) |
KRAMER KEVIN B |
Director | 44.41K | Purchase |
MENDES MEREDITH WISE |
Director | 19.30K | Stock Award(Grant) |
MOORE CECIL H JR |
Director | 36.32K | Stock Award(Grant) |
NACE ANDREW B |
Officer | 19.45K | Purchase |
REICHERT BART W |
Officer | 20.00K | Purchase |
SIMMONS MICHAEL SHAWN |
Chairman of the Board | 10.55K | Stock Award(Grant) |
TURNER R GERALD |
Director | 37.59K | Stock Award(Grant) |
Fundamentals
Market cap$904.67M
Enterprise value$1.47B
Revenue (TTM)$1.94B
Gross profit$233.30M
EBITDA$33.80M
Net income$-109.40M
EPS (TTM)$-0.95
Free cash flow$104.05M
Total cash$26.60M
Total debt$588.60M
Book value / share$6.53
Shares outstanding115.10M
Float21.50M
Short % of float5.01%
Dividend yield2.54%
Beta (5Y)1.07
Valuation & profitability ratios
Trailing P/E—
Forward P/E12.81
PEG ratio1.36
Price / sales—
Price / book1.20
EV / revenue0.76
EV / EBITDA43.39
Gross margin12.01%
Operating margin6.68%
Profit margin-5.63%
Return on equity-13.69%
Return on assets-0.98%
Debt / equity78.38
Current ratio3.30
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.86B | $1.89B | $1.67B | $1.93B | -1.5% |
| Operating revenue | $1.86B | $1.89B | $1.67B | $1.93B | -1.5% |
| Cost of revenue | $1.65B | $1.53B | $1.50B | $1.54B | +7.8% |
| Gross profit | $213.00M | $359.30M | $164.90M | $391.10M | -40.7% |
| Research & development | $16.00M | $14.00M | $18.00M | — | +14.3% |
| Selling, general & admin | $229.20M | $211.60M | $193.20M | $231.30M | +8.3% |
| Total operating expense | $254.90M | $238.00M | $222.30M | $243.00M | +7.1% |
| Operating income | -$41.90M | $121.30M | -$57.40M | $148.10M | -134.5% |
| Net interest income | -$51.80M | -$37.40M | -$10.20M | -$11.80M | -38.5% |
| Pre-tax income | -$97.40M | $149.60M | -$72.90M | $133.90M | -165.1% |
| Tax provision | $13.50M | $63.40M | -$23.80M | $29.40M | -78.7% |
| Net income | -$110.90M | $86.20M | -$49.10M | $104.50M | -228.7% |
| Net income to common | -$110.90M | $86.20M | -$49.10M | $104.50M | -228.7% |
| Basic EPS | -0.96 | 0.75 | -0.43 | 0.90 | -228.0% |
| Diluted EPS | -0.96 | 0.75 | -0.43 | 0.90 | -228.0% |
| EBIT | -$44.40M | $192.50M | -$55.80M | $150.80M | -123.1% |
| EBITDA | $20.40M | $256.90M | -$2.70M | $207.00M | -92.1% |
| Basic shares | 115.00M | 115.00M | 115.10M | 115.50M | 0.0% |
| Diluted shares | 115.00M | 115.00M | 115.10M | 115.50M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $33.20M | $106.70M | $194.70M | $327.80M | — | -68.9% |
| Cash & short-term investments | $33.20M | $106.70M | $194.70M | $327.80M | — | -68.9% |
| Accounts receivable | $270.70M | $269.20M | $273.60M | $220.30M | — | +0.6% |
| Inventory | $628.60M | $656.70M | $564.60M | $608.70M | — | -4.3% |
| Total current assets | $994.50M | $1.11B | $1.12B | $1.24B | — | -10.0% |
| Property, plant & equipment | $744.20M | $714.70M | $505.60M | $506.00M | — | +4.1% |
| Goodwill & intangibles | $2.60M | $2.60M | $0 | — | — | 0.0% |
| Total assets | $1.82B | $1.91B | $1.84B | $1.93B | — | -5.1% |
| Total current liabilities | $368.80M | $476.60M | $370.80M | $326.70M | — | -22.6% |
| Current debt | — | $78.30M | — | $1.10M | $1.40M | — |
| Long-term debt | $557.40M | $429.10M | $440.90M | $424.10M | — | +29.9% |
| Total debt | $577.30M | $528.00M | $463.40M | $446.40M | — | +9.3% |
| Total liabilities | $1.07B | $1.10B | $1.03B | $977.20M | — | -2.8% |
| Retained earnings | -$344.90M | -$211.00M | -$242.00M | -$105.40M | — | -63.5% |
| Shareholder equity | $751.10M | $817.00M | $808.30M | $957.20M | — | -8.1% |
| Working capital | $625.70M | $628.70M | $746.60M | $915.50M | — | -0.5% |
| Net tangible assets | $748.50M | $814.40M | $808.30M | $957.20M | — | -8.1% |
| Shares issued | 115.05M | 115.00M | 115.10M | 115.50M | — | +0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$110.90M | $86.20M | -$49.10M | $104.50M | -228.7% |
| Depreciation & amortisation | $64.80M | $64.40M | $53.10M | $56.20M | +0.6% |
| Change in working capital | $47.10M | -$42.30M | $36.20M | -$80.30M | +211.3% |
| Operating cash flow | $2.50M | $72.50M | $5.50M | $81.70M | -96.6% |
| Capital expenditure | -$42.90M | -$29.50M | -$47.40M | -$63.20M | -45.4% |
| Investing cash flow | -$42.90M | -$186.30M | -$47.40M | -$63.10M | +77.0% |
| Share buybacks | $0 | $0 | -$2.90M | -$2.30M | — |
| Dividends paid | -$23.00M | -$55.20M | -$87.50M | -$87.80M | +58.3% |
| Financing cash flow | -$36.30M | $26.50M | -$91.60M | -$91.50M | -237.0% |
| Free cash flow | -$40.40M | $43.00M | -$41.90M | $18.50M | -194.0% |
| End cash position | $42.50M | $114.70M | $202.10M | $334.60M | -62.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $558.10M | $509.80M | $418.30M | $456.90M | $494.40M | +9.5% |
| Operating revenue | $558.10M | $509.80M | $418.30M | $456.90M | $494.40M | +9.5% |
| Cost of revenue | $455.30M | $426.50M | $421.90M | $409.90M | $431.60M | +6.8% |
| Gross profit | $102.80M | $83.30M | -$3.60M | $47.00M | $62.80M | +23.4% |
| Selling, general & admin | $64.50M | $63.60M | $43.90M | $61.60M | $62.10M | +1.4% |
| Total operating expense | $64.70M | $65.30M | $61.70M | $64.30M | $64.80M | -0.9% |
| Operating income | $38.10M | $18.00M | -$65.30M | -$17.30M | -$2.00M | +111.7% |
| Net interest income | -$13.90M | -$14.10M | -$14.20M | -$13.90M | -$12.50M | +1.4% |
| Pre-tax income | $22.90M | -$2.00M | -$88.30M | -$29.10M | -$5.70M | +1,245.0% |
| Tax provision | $7.70M | $2.80M | -$5.50M | $7.90M | $3.50M | +175.0% |
| Net income | $15.20M | -$4.80M | -$82.80M | -$37.00M | -$9.20M | +416.7% |
| Net income to common | $15.20M | -$4.80M | -$82.80M | -$37.00M | -$9.20M | +416.7% |
| Basic EPS | 0.13 | -0.04 | -0.72 | -0.32 | -0.08 | +425.0% |
| Diluted EPS | 0.13 | -0.04 | -0.72 | -0.32 | -0.08 | +425.0% |
| EBIT | $37.10M | $12.30M | -$73.80M | -$15.00M | $7.10M | +201.6% |
| EBITDA | $54.00M | $28.90M | -$56.80M | $1.80M | $23.20M | +86.9% |
| Basic shares | 115.10M | 115.00M | 115.00M | 115.00M | 115.00M | +0.1% |
| Diluted shares | 115.10M | 115.00M | 115.00M | 115.00M | 115.00M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $26.60M | $25.70M | $33.20M | $27.70M | $18.90M | — | +3.5% |
| Cash & short-term investments | $26.60M | $25.70M | $33.20M | $27.70M | $18.90M | — | +3.5% |
| Accounts receivable | $373.40M | $357.90M | $270.70M | $319.40M | $320.90M | — | +4.3% |
| Inventory | $498.30M | $549.30M | $628.60M | $659.10M | $683.50M | — | -9.3% |
| Total current assets | $942.60M | $988.50M | $994.50M | $1.07B | $1.09B | — | -4.6% |
| Property, plant & equipment | $726.80M | $731.60M | $744.20M | $746.70M | $752.70M | — | -0.7% |
| Goodwill & intangibles | $2.60M | $2.60M | $2.60M | $2.60M | $2.60M | — | 0.0% |
| Total assets | $1.74B | $1.80B | $1.82B | $1.91B | $1.94B | — | -3.0% |
| Total current liabilities | $285.80M | $311.00M | $368.80M | $279.20M | $390.20M | — | -8.1% |
| Current debt | — | — | — | — | $87.90M | $81.20M | — |
| Long-term debt | $569.60M | $602.70M | $557.40M | $626.20M | $501.40M | — | -5.5% |
| Total debt | $588.60M | $621.50M | $577.30M | $647.10M | $610.60M | — | -5.3% |
| Total liabilities | $993.00M | $1.05B | $1.07B | $1.10B | $1.09B | — | -5.7% |
| Retained earnings | -$346.00M | -$355.50M | -$344.90M | -$256.40M | -$213.60M | — | +2.7% |
| Shareholder equity | $751.00M | $745.00M | $751.10M | $804.70M | $846.80M | — | +0.8% |
| Working capital | $656.80M | $677.50M | $625.70M | $791.20M | $697.40M | — | -3.1% |
| Net tangible assets | $748.40M | $742.40M | $748.50M | $802.10M | $844.20M | — | +0.8% |
| Shares issued | 115.05M | 115.05M | 115.05M | 115.04M | 115.04M | — | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $15.20M | -$4.80M | -$82.80M | -$37.00M | -$9.20M | — | +416.7% |
| Depreciation & amortisation | $16.90M | $16.60M | $17.00M | $16.80M | $16.10M | — | +1.8% |
| Change in working capital | $19.40M | -$66.40M | $164.60M | -$2.20M | $18.70M | — | +129.2% |
| Operating cash flow | $53.30M | -$51.30M | $92.10M | -$7.90M | $20.70M | — | +203.9% |
| Capital expenditure | — | -$10.20M | -$10.20M | — | — | -$12.00M | — |
| Investing cash flow | -$16.10M | -$10.20M | -$10.20M | -$9.50M | -$11.20M | — | -57.8% |
| Dividends paid | -$5.70M | -$5.80M | -$5.70M | -$5.80M | -$5.70M | — | +1.7% |
| Financing cash flow | -$36.20M | $53.10M | -$76.20M | $26.00M | -$13.20M | — | -168.2% |
| Free cash flow | $63.50M | -$61.50M | $81.90M | -$40.60M | $32.70M | — | +203.3% |
| End cash position | $34.50M | $33.60M | $42.50M | $36.40M | $27.70M | — | +2.7% |
Options analytics
Put / call volume
0.25
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
5.00
-36.4% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
+12.5%
Puts bid over calls
Call volume
8
Contracts, this expiry
Put volume
2
Contracts, this expiry
Heaviest call OI
5.00
0 contracts
Heaviest put OI
5.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.07 | 0.13 | +85.7% |
| Mar 2026 | -0.12 | -0.04 | +66.7% |
| Dec 2025 | -0.23 | -0.72 | -213.0% |
| Sep 2025 | -0.06 | -0.32 | -433.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.19 | 2 | $537.26M | +17.6% |
| Next quarter | 0.12 | 2 | $459.78M | +9.9% |
| Current year | 0.40 | 2 | $2.06B | +11.1% |
| Next year | 0.61 | 2 | $2.10B | +1.8% |
Analyst targets & ownership
Mean target$8.50
High target$9.00
Low target$8.00
Implied upside8.14%
Analyst count2
ConsensusNONE
Strong buy / Buy0 / 1
Hold0
Sell / Strong sell1 / 0
Held by insiders81.27%
Held by institutions16.92%
Institutions holding181
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
7.97
-1.37% from price
SMA 20
8.08
-2.74% from price
SMA 50
7.99
-1.61% from price
SMA 100
7.32
+7.41% from price
SMA 200
6.63
+18.57% from price
EMA 12
7.97
-1.35% from price
EMA 26
8.05
-2.31% from price
EMA 50
7.88
-0.31% from price
RSI (14)
46.0
Neutral
MACD (12,26,9)
-0.08
Hist -0.06
ATR (14)
0.31
3.96% of price
Realised vol 30D
39.5%
Annualised
Bollinger upper
8.56
20, 2σ
Bollinger lower
7.60
20, 2σ
50 / 200 cross
Golden
7.99 vs 6.63
Trend bias
Above 200
+18.57%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.31
More volatile than market
Correlation to SPY
0.28
Largely independent
Realised vol 30D
39.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-27.2%
Peak to trough
Max drawdown 5Y
-77.9%
Peak to trough
ATR 14
0.31
3.96% of price
Beta (reported)
1.07
5Y monthly, from filing
Short interest
Shares short
1.08M
Prior 1.00M
Change vs prior
+7.6%
Shorts adding
% of float
5.01%
Normal
% of shares out
0.94%
Against total outstanding
Days to cover
2.9
Liquid
Float
21.50M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 25, 26 | Deutsche Bank | MAINTAINED | Buy | Buy |
| Dec 17, 25 | Goldman Sachs | MAINTAINED | Sell | Sell |
| Oct 17, 25 | Goldman Sachs | MAINTAINED | Sell | Sell |
| May 28, 25 | Barclays | MAINTAINED | Underweight | Underweight |
| May 14, 25 | Goldman Sachs | MAINTAINED | Sell | Sell |
| Sep 25, 24 | Barclays | MAINTAINED | Underweight | Underweight |
| May 28, 24 | Deutsche Bank | MAINTAINED | Buy | Buy |
| May 16, 24 | Goldman Sachs | MAINTAINED | Sell | Sell |
| May 15, 24 | Barclays | MAINTAINED | Underweight | Underweight |
| Mar 26, 24 | Barclays | MAINTAINED | Underweight | Underweight |
| Mar 11, 24 | Goldman Sachs | MAINTAINED | Sell | Sell |
| Dec 14, 23 | Goldman Sachs | MAINTAINED | Sell | Sell |
Dividends & splits
Forward rate$0.20 / yr
Forward yield2.54%
5-year avg yield4.90%
Payout ratio33.90%
Ex-dividend dateSep 3, 2026
Next pay dateSep 17, 2026
Last split2:1
Split dateMay 23, 2011
SEC filings
Periodic Financial Reports
10-Q · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-05-13
Corporate Changes & Voting Matters
8-K · 2026-05-06
Proxy Statements
DEF 14A · 2026-03-24
Corporate Changes & Voting Matters
8-K · 2026-03-09
Corporate Changes & Voting Matters
8-K · 2026-02-25
Periodic Financial Reports
10-Q · 2025-11-06
Corporate Changes & Voting Matters
8-K · 2025-10-29
Headlines
Nutrien to Indefinitely Shut Down Trinidad Nitrogen Operations
Zacks · 19h ago
KWR Strengthens Capital Structure With Term Loan B Refinancing
Zacks · 2d ago
Sherwin-Williams Expands Manufacturing Capacity at Statesville
Zacks · 6d ago
NGVT Stock Rallies 31% in a Year: What's Driving the Upside?
Zacks · 7d ago
Westlake to Close Cologne PVC Plant Amid Weak European Market
Zacks · 7d ago
FMC Submits Rimisoxafen Regulatory Filing for Approval in Brazil
Zacks · 8d ago
Westlake Royal Expands Distribution Partnership With BlueLinx
Zacks · 9d ago
BASFY Launches Lower-Carbon Paper Coating Dispersions
Zacks · 12d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.